With Vik, Wefight helps sick people break out of their isolation
The startup created a virtual companion as a mobile application that improves the daily lives of patients with chronic diseases or cancer. Success has encouraged Wefight to expand its solution’s fe...
Phost’In, soon to be the European champion in invasive cancer treatment
After finalizing fundraising for 10.3 M€ in April and consolidating its scientific team, the Montpellier-based biotech company has just confirmed additional funding of 2.5 M€.
Health: when innovation takes on a feminine focus
Health, one of Montpellier Métropole’s excellence sectors, is highly favorable for women. From Genepep to Sensorion, they run their companies and occupy their rightful place in national and interna...
Neurinnov, a solution for regaining hand control
Montpellier startup Neurinnov is in the process of developing HandyGrasp, an unprecedented medical device. Assisted by Montpellier BIC, the promising young company is at the heart of the local heal...
Health, a pillar for development in Montpellier !
A place for success and innovation, Montpellier has earned widespread international recognition in the health ﬁeld.
Health, a pillar for development in Montpellier
Celebrate University of Montpellier Medical School’s 800th anniversary
The world’s oldest medical school still in activity, University of Montpellier’s Faculty of Medicine, is celebrating its 800 years on August 17, 2020. You are invited to participate in events organ...
Genious Healthcare joins the ranks of the Swiss pioneer MindMaze
By acquiring Genious Healthcare, therapeutic video games developer, the Swiss pioneer MindMaze establishes itself in Montpellier.
DeepTech Tour in Montpellier
Mark your calendar on January 9 in Montpellier for the DeepTech Tour, a veritable gateway between the research and entrepreneurial worlds. The objective is to bring momentum to the city regarding ...
Biodol Therapeutics invents a remedy for chronic pain
Incubated at Montpellier BIC, Montpellier startup Biodol Therapeutics is developing the first medicine specifically for chronic neuropathic pain that affects millions of patients. A gem for Montpel...